FDA Under Pressure to Grant Swift EUA for Moderna’s Vaccine for Young Children

Moderna announced yesterday that it has filed for FDA Emergency Use Authorization (EUA) of its two-dose COVID-19 vaccine in children less than six years old as the FDA comes under intense pressure from many sides to swiftly authorize the vaccine for this population.
Source: Drug Industry Daily